BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 19052726)

  • 1. Sigma1 receptor antagonists determine the behavioral pattern of the methamphetamine-induced stereotypy in mice.
    Kitanaka J; Kitanaka N; Tatsuta T; Hall FS; Uhl GR; Tanaka K; Nishiyama N; Morita Y; Takemura M
    Psychopharmacology (Berl); 2009 May; 203(4):781-92. PubMed ID: 19052726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of brain histamine metabolism alters methamphetamine-induced expression pattern of stereotypy in mice via histamine H1 receptors.
    Kitanaka J; Kitanaka N; Tatsuta T; Morita Y; Takemura M
    Neuroscience; 2007 Jul; 147(3):765-77. PubMed ID: 17570600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Straub tail reaction in mice treated with σ(1) receptor antagonist in combination with methamphetamine.
    Kitanaka J; Kitanaka N; Hall FS; Uhl GR; Tanaka K; Nishiyama N; Takemura M
    Brain Res; 2012 Oct; 1482():40-6. PubMed ID: 22981417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histamine H3 receptor agonists decrease hypothalamic histamine levels and increase stereotypical biting in mice challenged with methamphetamine.
    Kitanaka J; Kitanaka N; Hall FS; Uhl GR; Tatsuta T; Morita Y; Tanaka K; Nishiyama N; Takemura M
    Neurochem Res; 2011 Oct; 36(10):1824-33. PubMed ID: 21573995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The selective μ opioid receptor antagonist β-funaltrexamine attenuates methamphetamine-induced stereotypical biting in mice.
    Kitanaka J; Kitanaka N; Hall FS; Uhl GR; Fukushima Y; Sawai T; Watabe K; Kubo H; Takahashi H; Tanaka K; Nishiyama N; Tatsuta T; Morita Y; Takemura M
    Brain Res; 2013 Jul; 1522():88-98. PubMed ID: 23727404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretreatment with l-histidine produces a shift from methamphetamine-induced stereotypical biting to persistent locomotion in mice.
    Kitanaka J; Kitanaka N; Tatsuta T; Miyoshi A; Koumoto A; Tanaka K; Nishiyama N; Morita Y; Takemura M
    Pharmacol Biochem Behav; 2010 Jan; 94(3):464-70. PubMed ID: 19895842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrathecal treatment with sigma1 receptor antagonists reduces formalin-induced phosphorylation of NMDA receptor subunit 1 and the second phase of formalin test in mice.
    Kim HW; Kwon YB; Roh DH; Yoon SY; Han HJ; Kim KW; Beitz AJ; Lee JH
    Br J Pharmacol; 2006 Jun; 148(4):490-8. PubMed ID: 16682960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agmatine attenuates methamphetamine-induced hyperlocomotion and stereotyped behavior in mice.
    Kitanaka N; Kitanaka J; Hall FS; Uhl GR; Watabe K; Kubo H; Takahashi H; Tanaka K; Nishiyama N; Takemura M
    Behav Pharmacol; 2014 Apr; 25(2):158-65. PubMed ID: 24557322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The sigma receptor ligand (+/-)-BMY 14802 prevents methamphetamine-induced dopaminergic neurotoxicity via interactions at dopamine receptors.
    Terleckyj I; Sonsalla PK
    J Pharmacol Exp Ther; 1994 Apr; 269(1):44-50. PubMed ID: 7513362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of effect of anticonvulsant topiramate on methamphetamine-induced stereotypy and rewarding property in mice.
    Tatsuta T; Kitanaka N; Kitanaka J; Morita Y; Takemura M
    Pharmacol Biochem Behav; 2007 May; 87(1):48-55. PubMed ID: 17482247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo functional interaction between phencyclidine binding sites and sigma receptors to produce head-weaving behavior in rats.
    Kitaichi K; Noda Y; Hasegawa T; Furukawa H; Nabeshima T
    Eur J Pharmacol; 1996 Dec; 318(2-3):205-11. PubMed ID: 9016907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidences for the involvement of sigma receptors in antidepressant like effect of quetiapine in mice.
    Kotagale NR; Mendhi SM; Aglawe MM; Umekar MJ; Taksande BG
    Eur J Pharmacol; 2013 Feb; 702(1-3):180-6. PubMed ID: 23399765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropeptide S attenuates methamphetamine-induced stereotyped behavior in rats.
    Li X; Jiang F; Yao K; Yang L; Gao X; Chen H; Wei X; Wu N; Zhou R; Yuan W; Zhang S
    Biochem Biophys Res Commun; 2020 Jun; 527(1):98-103. PubMed ID: 32446398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (+)-SKF-10,047 and dextromethorphan ameliorate conditioned fear stress via dopaminergic systems linked to phenytoin-regulated sigma 1 sites.
    Kamei H; Kameyama T; Nabeshima T
    Eur J Pharmacol; 1996 Aug; 309(2):149-58. PubMed ID: 8874133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (+)-SKF-10,047 and dextromethorphan ameliorate conditioned fear stress through the activation of phenytoin-regulated sigma 1 sites.
    Kamei H; Kameyama T; Nabeshima T
    Eur J Pharmacol; 1996 Mar; 299(1-3):21-8. PubMed ID: 8901003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The sigma receptor agonist SA4503 both attenuates and enhances the effects of methamphetamine.
    Rodvelt KR; Oelrichs CE; Blount LR; Fan KH; Lever SZ; Lever JR; Miller DK
    Drug Alcohol Depend; 2011 Jul; 116(1-3):203-10. PubMed ID: 21277708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of sigma (sigma) receptors in the acute actions of methamphetamine: receptor binding and behavioral studies.
    Nguyen EC; McCracken KA; Liu Y; Pouw B; Matsumoto RR
    Neuropharmacology; 2005 Oct; 49(5):638-45. PubMed ID: 15939443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of UMB24 and (+/-)-SM 21, putative sigma2-preferring antagonists, on behavioral toxic and stimulant effects of cocaine in mice.
    Matsumoto RR; Pouw B; Mack AL; Daniels A; Coop A
    Pharmacol Biochem Behav; 2007 Jan; 86(1):86-91. PubMed ID: 17241657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of monoamine oxidase inhibitors on methamphetamine-induced stereotypy in mice and rats.
    Tatsuta T; Kitanaka N; Kitanaka J; Morita Y; Takemura M
    Neurochem Res; 2005 Nov; 30(11):1377-85. PubMed ID: 16341934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sigma (sigma) antagonist BMY 14802 prevents methamphetamine-induced sensitization.
    Ujike H; Kanzaki A; Okumura K; Akiyama K; Otsuki S
    Life Sci; 1992; 50(16):PL129-34. PubMed ID: 1313134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.